"NO" controversy?: A controversial role in insulin signaling of diabetic encephalopathy

Xi Chen,Ying Song,Ye Hong,Xiaomin Zhang,Qisong Li,Hongling Zhou
DOI: https://doi.org/10.1016/j.mce.2024.112346
2024-11-01
Abstract:Insulin, a critical hormone in the human body, exerts its effects by binding to insulin receptors and regulating various cellular processes. While nitric oxide (NO) plays an important role in insulin secretion and acts as a mediator in the signal transduction pathway between upstream molecules and downstream effectors, holds a significant position in the downstream signal network of insulin. Researches have shown that the insulin-NO system exhibits a dual regulatory effect within the central nervous system, which is crucial in the regulation of diabetic encephalopathy (DE). Understanding this system holds immense practical importance in comprehending the targets of existing drugs and the development of potential therapeutic interventions. This review extensively examines the characterization of insulin, NO, Nitric oxide synthase (NOS), specific NO pathway, their interconnections, and the mechanisms underlying their regulatory effects in DE, providing a reference for new therapeutic targets of DE.
What problem does this paper attempt to address?